Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions
- May 1st, 2007
- Medical Abortion
- Aldrich, T., Winikoff, B.
BJOG; 2007 May; 114(5):555-62; doi:10.1111/j.1471-0528.2007.01274.x
This article reports on a study comparing efficacy of four medical abortion regimens used in one clinic setting in a highly restrictive Latin American country. In this real-use setting, methotrexate appears to confer a significant advantage over misoprostol alone for early medical abortion. This finding is important for settings where mifepristone remains unavailable.